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Abstract Purpose: To study the
value of free versus total cortisol
levels in assessing relative adrenal
insufficiency during critical illness-
related corticosteroid insufficiency.
Methods: A prospective study in a
mixed intensive care unit from 2004
to 2007. We consecutively included
49 septic and 63 non-septic patients
with treatment-insensitive hypoten-
sion in whom an adrenocorticotropic
hormone (ACTH) test (250 lg) was
performed. Serum total and free cor-
tisol (equilibrium dialysis),
corticosteroid-binding globulin
(CBG) and albumin were assessed.
Results: Although a low CBG
resulted in a high free cortisol level
relative to total cortisol, free and total
cortisol and their increases were well
correlated (r = 0.77–0.79,
P \ 0.001). In sepsis, hypoalbumi-
nemia did not affect total and free
cortisol, and increases in total cortisol
upon ACTH predicted increases in
free cortisol regardless of low binding
proteins. In non-sepsis, total cortisol
was lower with than without hypoal-
buminemia; free cortisol did not
differ, since hypoalbuminemia con-
curred with a low CBG. Increases in
total cortisol depended less on bind-
ing proteins than on raw levels. The
areas under the receiver operating
characteristic curve for predicting
increases in free from total cortisol
were 0.93–0.97 in sepsis and
0.79–0.85 in non-sepsis (P = 0.044
or lower for sepsis vs. non-sepsis).
Conclusions: Although the biologi-
cally active free cortisol fraction
depends on binding proteins, total
cortisol correlates to free cortisol in
treatment-insensitive hypotension
during critical illness. In sepsis,
albumin is not an important binding
molecule. Subnormal increments in
total cortisol upon ACTH suffice in
assessing relative adrenal insuffi-
ciency, particularly in sepsis.
Keywords Adrenocorticotropic
hormone  Corticosteroid-binding
globulin  Equilibrium dialysis 
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Introduction
Severe illness activates the hypothalamic-pituitary-adre-
nal (HPA) axis [1]. Relatively insufficient adrenal
secretion of cortisol for the severity of illness, in the
course of critical illness-related corticosteroid insuffi-
ciency (CIRCI), commonly occurs in the critically ill.
This may warrant treatment by corticosteroids to survive
septic shock, although this is hotly debated [2–7]. Adrenal
function is mostly assessed by total cortisol measurements
prior to and after injection of adrenocorticotropic hor-
mone (ACTH). Insufficiency is usually defined at cutoffs
of peak levels, increases of circulating cortisol upon
ACTH (\250 nmol/l) or combinations of these [1–3, 5].
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We found a lower cutoff (\100 nmol/l) for ACTH-
induced increases to be associated with mortality and
predicted a survival benefit of corticosteroid treatment in
septic shock [6].
Foregoing studies can be criticized because of changes
in binding proteins such as cortisol-binding globulin
(CBG) and albumin, confounding estimation of biologi-
cally active free cortisol from total cortisol measurements
and thereby assessment of adrenal function [1, 4, 5, 7–20].
Indeed, low binding proteins may overestimate relative
adrenal insufficiency assessed from (increases in) total
cortisol. This issue was refuted by others, however [5, 15,
21]. Differences in case mix may partly underlie the
discrepancies between studies, because of healthy vol-
unteers or non-septic patients predominating in some
studies [4, 11, 14, 17] and of septic patients in others
[5, 15, 21]. Moreover, CIRCI may be more frequent in
sepsis than in non-sepsis patients, and sometimes only
calculated free cortisol was evaluated, thereby assuming
normal albumin levels, while both CBG and albumin may
be lowered [1–3, 5, 6, 8, 18, 22, 23]. We previously used
(increases in) cortisol/albumin ratios to adjust for protein
binding in critical illness, but these ratios were not vali-
dated, even though CBG and albumin levels commonly
change in the same direction, and hypoalbuminemia has
been suggested to increase the free cortisol fraction [4, 6,
18]. Other authors, however, suggest that CBG and
albumin and their cortisol binding are differently regu-
lated in sepsis as compared to non-sepsis [8, 18, 23, 24].
Free cortisol can be directly measured by equilibrium
dialysis, which is not routinely used because of its non-
automated and laborious nature [4, 13, 15–17, 25, 26].
The aim of the current study was to investigate the
value of total cortisol versus free cortisol (by equilibrium
dialysis) measurements for the assessment of relative
adrenal insufficiency in the critically ill undergoing a
250-lg ACTH test for suspected CIRCI. Furthermore, we
analyzed the effects of CBG and albumin levels, and
separately studied septic and non-septic patients. The
hypothesis was that binding molecules affect free cortisol
for a given total cortisol level, and thereby confound
diagnosis of adrenal insufficiency from total cortisol
levels, depending on the underlying condition.
Patients and methods
Patient population and ACTH test
This prospective study was carried out in the intensive
care unit (ICU) of a university hospital from December
2004 to March 2007. Dutch legislation waived the need
for informed consent as the ACTH test is routinely per-
formed in our department, no extra blood was drawn for
this study, and the results were treated anonymously. One
hundred twelve critically ill patients over 18 years old
with a clinical suspicion of CIRCI on the basis of [6 h
hypotension (\100 mmHg systolic) requiring repeated
fluid challenges and/or vasopressor/inotropic treatment
were consecutively included. Patients were excluded if
they had a history of hypothalamic-pituitary or adrenal
disease, or if they received glucocorticoid treatment
within 3 months of testing.
All patients underwent a short 250 lg ACTH (tetra-
cosactide-hexa-acetate, Synacthen, Novartis Pharma,
Basel Switzerland) test. Blood samples were taken at
baseline and 30 and 60 min after intravenous injection.
Serum total cortisol was measured by competitive
immunoassay (Advia Centaur, Siemens Diagnostics,
Deerfield, IL). The intra- and interassay coefficients of
variation (CV) are 3 and 6%, respectively, and the detec-
tion limit was 30 nmol/l (500 nmol/l = 18 lg/dl). The
peak (at 30 or 60 min) minus baseline cortisol level was
taken to calculate increases upon ACTH. A subnormal
response to ACTH in critical illness was defined by a total
cortisol increase\250 nmol/l or increase\100 nmol/l, as
reported by others and ourselves [5, 6]. Serum free cortisol
levels were measured by equilibrium dialysis of undiluted
serum samples followed by radioimmunoassay (Orion
Diagnostica, Espoo, Finland; \6% cross reactivity with
cortisone) [4, 13, 16, 17, 25, 26]. The intra- and interassay
coefficients of variation were less than 7 and 8%,
respectively. See the electronic supplement for more
information about how total cortisol, free cortisol, ACTH,
CBG and albumin were measured.
Data collection
At study entry, the day of the ACTH test, the following
parameters were recorded: time from ICU admission, age
and sex, ICD-10 definitions of common clinical condi-
tions at admission and the severity of illness, as assessed
by the Acute Physiology, Age and Chronic Health Eval-
uation (APACHE) II scores. Sepsis was defined as the
presence of systemic inflammatory response syndrome
(SIRS) with a positive microbiological local (urine, tra-
chea or other) and/or blood culture. SIRS was defined as
two or more of the following criteria: a temperature[38
or\35.5C, a leukocyte count[12 or\4 9 109/l, a heart
rate [90/min, and a respiratory rate [20/min or the
presence of mechanical ventilation. Suspected or micro-
biologically proven sources of sepsis were recorded.
Laboratory measurements included total white blood cells
and serum levels of CBG, albumin and creatinine. Inter-
ventions including type and doses of vasopressor/
inotropes, intubation, use of etomidate in the preceding
48 h to facilitate endotracheal intubation, need for
mechanical ventilation and renal replacement therapy
were recorded. During follow-up, 28-day and ICU mor-
tality and length of ICU stay were recorded.
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Statistical analysis
Data were distributed normally (Kolmogorov-Smirnov
test P [ 0.05), except for increases in cortisol. The CBG
and albumin levels obtained at baseline were also used for
30 and 60 min, since they were assumed not to change
in this time interval [5, 13]. Data were arbitrarily
dichotomized around median CBG and albumin levels.
Categorical data were compared with the use of the
chi-square test and Fisher’s exact tests. When appropriate
the Pearson or partial correlation coefficients were used
to express relations between variables. Furthermore, we
performed generalized estimating equations (GEE),
multivariable analyses, Mann-Whitney U test and recei-
ver-operating characteristic curves (see the electronic
supplement for the detailed information). A two-sided
P \ 0.05 was considered to indicate statistical signifi-
cance, and exact P values\0.10 are given, unless\0.001.
Data are expressed as median (interquartile range).
Results
Patient characteristics (Table 1)
Forty-four percent of patients had sepsis on the test day,
and 43% of the latter had an increase of total cortisol
\250 nmol/l upon exogenous ACTH. Septic patients
frequently received vasopressor/inotropic support and
therefore mostly suffered from septic shock. Sources and
associated microorganisms were tabulated. Fifty-six per-
cent of patients had non-sepsis and 43% of the latter a
total cortisol response \250 nmol/l. A cortisol response
\100 nmol/l occurred in 14% of septic and in 13% of
non-septic patients (ns). Body temperature was 37.3 ±
1.5C and 36.4 ± 1.5C in sepsis and non-sepsis patients
(P = 0.010), respectively. Non-septic patients had
slightly higher APACHE II scores than septic patients,
with 17 ± 8 and 16 ± 5, respectively (P = 0.039), and
scores were higher in non-survivors (P = 0.013).
Twenty-eight-day survivors had received hydrocortisone
replacement doses in 92% and non-survivors in 82% (ns).
Free, total cortisol and increases in sepsis
and non-sepsis
Baseline free and total cortisol levels were somewhat
directly related to the APACHE II score (minimum
r = 0.19, P = 0.043 or lower). Both increases in free and
total cortisol inversely related to the respective baselines
(minimum r = -0.23, P = 0.013). Patients with sepsis
had higher free (and not total) cortisol levels at baseline,
30 and 60 min than non-septic patients, whereas binding
proteins and cortisol increases upon ACTH did not differ
(Table 1 in electronic supplement). Patients with an
increase of total cortisol \250 or \100 nmol/l upon
ACTH had lower free cortisol increases, regardless of the
underlying condition, than those with greater increases in
total cortisol (Table 2). In sepsis, free related to total
cortisol for raw values (partial r = 0.79, P \ 0.001,
Figure in electronic supplementary material). Increases in
Table 1 Patient demographics and characteristics (n = 112)
Age (years) 66 (22)
Sex (m/f) 65 (58)/47 (42)
Admission syndromesa
Trauma and postoperative 41 (37)
Cardiac surgery 19 (17)
Vascular surgery 6 (5)
Respiratory failure 38 (34)
Post-CPR 12 (11)
Shock 11 (10)
Sepsis 15 (13)
Renal insufficiency 4 (4)
Coma 1 (1)
Other 34 (30)
Length of stay (days) 15 (22)
Mortality day 28 (25)
Mortality ICU 35 (31)
At day of ACTH test
Time admission to test (days) 2 (4)
APACHE II 17 (6)
SIRS 93 (83)
Non-sepsis 63 (56)
Sepsis 49 (44)
Sourcea
Respiratory 32 (65)
Abdominal 9 (18)
Urogenital 2 (4)
Neurological 1 (2)
Catheter 1 (2)
Miscellaneous 7 (14)
Microorganisma
Gram-negative 34 (69)
Gram-positive 17 (35)
Fungal 7 (14)
Bacteremiaa
Gram-negative 6 (12)
Gram-positive 8 (16)
Fungal 2 (4)
Mechanical ventilation 82 (73)
Renal replacement therapy 13 (12)
MAP (mmHg) 76 (21)
Vasopressors/inotropes 101 (90)
Norepinephrine, number (dose in mg/h) 93 (83), 0.16 (0.61)
Dopamine (number) 16 (14)
Enoximone (number) 28 (25)
Etomidate \48 h prior to test 32 (28)
Start hydrocortisone after test 100 (93)
Duration (days) 8 (10)
Cumulative dose (mg) 1213 (1250)
Data are expressed as median (interquartile range) or number (%),
where appropriate
CPR Cardiopulmonary resuscitation, ICU intensive care unit,
APACHE Acute Physiology, Age and Chronic Health Evaluation
score, ACTH adrenocorticotropic hormone, SIRS systemic inflam-
matory response syndrome, MAP mean arterial pressure
a Patients may have more than one
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free cortisol correlated with total cortisol at r = 0.79
(P \ 0.001; Fig. 1), whereas percentage increases of free
were greater than those of total cortisol (P \ 0.001). For
non-septic patients, free cortisol correlated at partial
r = 0.77 to total cortisol for raw values (P \ 0.001,
Figure in electronic supplementary material). Increases in
free cortisol correlated at r = 0.77 to total cortisol
increases (P \ 0.001; Fig. 1). Percentual increases of the
former were greater (P \ 0.001). In both conditions,
greater percentual increases in free than total cortisol can
be attributed to ACTH-induced increases in the free
cortisol fraction. However, differences in percentual
increases in free and total cortisol were less when
responses to ACTH were less. In Table 3 statistically
significant clinical correlates of free cortisol (76 nmol/l
cutoff, see below) and total cortisol (250 nmol/l cutoff)
increases are compared. It is shown that trauma and sur-
gery as reasons for admission were less, and the use of
etomidate was more common when free and total cortisol
responses were lower. There were no hydrocortisone
treatment differences between the groups.
Endogenous ACTH
Endogenous ACTH was directly related to the APACHE
II score (r = 0.44, P \ 0.001) and to baseline free and
total free cortisol (r = 0.33 or higher, P = 0.001 or
lower). It was inversely correlated to the increase in free
and total cortisol upon exogenous ACTH (r = -0.30 and
-0.19, P = 0.003 and 0.058, respectively), so that
endogenous ACTH levels were relatively high at low
cortisol responses to exogenous ACTH (Table 2).
Binding proteins; sepsis and non-sepsis
Albumin related poorly to CBG (r = 0.23, P = 0.007) in
sepsis, but better (r = 0.43, P \ 0.001) in non-sepsis,
whereas both binding protein levels were subnormal.
Total cortisol and CBG predicted free cortisol in sepsis
(GEE, P \ 0.001), while albumin did not contribute. In
non-sepsis, both CBG and albumin (and first order
interactions) contributed to the relation between free and
total cortisol (GEE, P = 0.036 or lower). Increases in free
cortisol were related to increases in total cortisol (GEE,
P \ 0.001), without a significant contribution of binding
proteins in sepsis, but this was dependent on both proteins
(and first order interactions) in non-sepsis (GEE,
P = 0.020 or lower; Fig. 1). Indeed, free cortisol at
baseline, 30 and 60 min was higher with lower CBG,
particularly in septic patients, while total cortisol was
similar regardless of underlying condition (Table 2 in
electronic supplement). Hypoalbuminemia did not affect
free and total cortisol levels at baseline, 30 and 60 min in
sepsis (Table 3 in electronic supplement). However,
being paralleled by a low CBG, hypoalbuminemia was
associated with relatively low total (but not free) cortisol
levels in non-septic patients. The increases in free and
total cortisol were less affected by CBG and albumin than
raw cortisol levels in both underlying conditions and less
so in sepsis than in non-sepsis patients (Fig. 1).
Diagnostic values
For both underlying conditions, the optimal cutoff of free
cortisol increases with the highest sensitivity and
Table 2 Results according to cortisol response to ACTH
Cortisol increase P Cortisol increase P
C250 nmol/l
(n = 64)
\250 nmol/l
(n = 48)
C100 nmol/l
(n = 97)
\100 nmol/l
(n = 15)
CBG (mg/l) 25 (11) 24 (10) 25 (11) 27 (16)
Albumin (g/l) 18 (9) 17 (10) 18 (9) 14 (4) 0.079
ACTH (pmol/l) 1.8 (1.3) 3.1 (6.6) \0.001 1.9 (1.8) 6.4 (17.1) 0.002
Total cortisol (nmol/l)
Baseline 420 (253) 520 (326) 445 (312) 500 (540)
30 min 725 (381) 635 (625) 675 (339) 625 (523)
60 min 875 (395) 715 (349) 790 (374) 545 (570)
Increase (nmol/l) 405 (215) 140 (125) na 305 (240) 60 (45) na
Increase (%) 102 (86) 24 (26) na 70 (92) 10 (10) na
Free cortisol (nmol/l)
Baseline 82 (108) 134 (132) 92 (111) 139 (219)
30 min 202 (123) 158 (141) 190 (126) 137 (175)
60 min 234 (125) 187 (131) 210 (142) 175 (207)
Free cortisol (% of total cortisol)
24 (11) 24 (9) 24 (11) 25 (7)
Increase (nmol/l) 132 (68) 40 (46) \0.001 103 (93) 22 (33) \0.001
Increase (%) 176 (201) 32 (64) \0.001 112 (194) 8 (26) \0.001
Data are expressed as median (interquartile range); exact P \ 0.10
CBG Cortisol-binding globulin; ACTH adrenocorticotropic hormone, na not applicable
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specificity in the ROC curve for predicting total cortisol
increases\250 nmol/l was 76 nmol/l. In sepsis, the AUC
of the ROC curve of total cortisol increases predicting an
increase in free cortisol\76 nmol/l was 0.97 (P \ 0.001).
In non-sepsis, the AUC was 0.85 (P \ 0.001, P = 0.024
sepsis vs. non-sepsis). For both underlying conditions, the
optimal cutoff of the free cortisol increase with the
highest sensitivity and specificity in the ROC curve for
predicting total cortisol increases \100 nmol/l was
40 nmol/l. In sepsis, the AUC of the ROC curve of total
A
B
C
D
R=0.79, p<0.001
R=0.77, p<0.001
Fig. 1 Increases upon ACTH of
free (measured by equilibrium
dialysis) versus total cortisol in
the critically ill patients with
sepsis (a, c) or non-sepsis
(b, d), according to
dichotomized levels of cortisol
binding globulin (CBG;
a, b) and albumin (c, d).
R Partial correlation
coefficient
Table 3 Statistically significant clinical correlates of free and total cortisol responses to ACTH
Free cortisol increase P Total cortisol increase P
C76 nmol/l
n = 62
\76 nmol/l
n = 49
C250 nmol/l
n = 64
\250 nmol/l
n = 48
Admission
APACHE II 16 (7) 17 (6) 0.156 15 (6) 17 (6) 0.037
Trauma and postoperative 29 (47) 12 (24) 0.018 29 (45) 12 (25) 0.031
Respiratory failure 17 (27) 20 (41) 0.159 16 (25) 22 (46) 0.027
Shock 1 (2) 10 (20) 0.002 6 (9) 5 (10) 0.525
Test day
Etomidate \48 h 10 (16) 23 (47) \0.001 12 (19) 21(44) 0.006
Norepinephrine (mg/h) 0.04 (0.08) 0.03 (0.25) 0.594 0.03 (0.05) 0.04(0.04) 0.382
Day 28
Mortality 13 (21) 15 (31) 0.276 10 (16) 18 (38) 0.014
Data are expressed as median (interquartile range) or number (percentage), where appropriate; exact P \ 0.10
ACTH Adrenocorticotropic hormone
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cortisol increases predicting an increase in free cortisol
\40 nmol/l was 0.93 (P \ 0.001) and in non-sepsis 0.79
(P = 0.001, P = 0.044 sepsis vs. non-sepsis).
Discussion
Our results suggest that total cortisol closely correlates to
free cortisol in critically ill, septic and non-septic patients
with suspected CIRCI, even though the biologically
active free cortisol fraction depends on binding proteins
and free cortisol better parallels severity of disease than
total cortisol. In sepsis, albumin is a less important
binding molecule than in non-sepsis, and levels cannot be
used to predict free from total cortisol. Finally, increases
in free cortisol upon ACTH depend less on low binding
proteins than raw levels, so that increases in total cortisol
suffice in assessing adrenal insufficiency, particularly in
sepsis.
CBG is the major cortisol binding-protein in blood, so
that, as our data confirm, the free cortisol fraction is only
about 25% of total cortisol even in the critically ill, and
direct measurements are needed when trying to assess free
from total cortisol levels [1, 4, 5, 9, 11, 14–18]. Cortisol
binding to CBG is saturable (690 nmol/l) and character-
ized by a molar binding ratio at high affinity [18]. By
contrast, cortisol binding to albumin has low affinity, is
non-saturable and is characterized by complex stoichi-
ometry and interactions [18]. Dorin et al. [18] described
that albumin-bound and free cortisol fractions increase,
whereas the CBG-bound cortisol fraction declines at
increasing levels of total cortisol. This leads to a pre-
dominance of albumin-bound cortisol at high cortisol
levels and in case of combined CBG and albumin defi-
ciency. The latter may thus help to explain the lower total
(rather than free) cortisol levels in non-septic, hypoalb-
uminemic patients with a relatively low CBG vs. those
with higher protein levels, in line with the results in
predominantly non-septic patients studied by Hamrahian
et al. [4]. In contrast, hypoalbuminemia in septic patients
was not associated with a low and potentially saturated
CBG, and thus low total and high free cortisol, in line
with others [5, 15]. CBG and albumin apparently often
change in dissimilar directions in sepsis as compared to
non-sepsis, as suggested before [18]. Hence, the cortisol/
albumin ratios used to adjust for protein binding are
probably invalid in this condition [6]. Moreover, the
affinity of cortisol may be lowered in sepsis when albu-
min molecules are damaged [24]. Together with the
reported lowered binding capacity of cortisol for CBG in
febrile sepsis [8, 23], this may also explain why CBG
rather than albumin affected free cortisol in sepsis and
even less so than in non-sepsis. In any case, free cortisol
was closely related to total cortisol levels, regardless of
the underlying conditions, so that both free and total
cortisol levels increased in relation to severity of illness,
as reported before [4, 6, 16]. Nevertheless, total cortisol
somewhat underestimated a higher free cortisol, as
observed before [14, 15, 17], in sepsis as compared to
non-sepsis. However, both free and total cortisol was
directly related to APACHE II scores and endogenous
ACTH levels, suggesting HPA axis activation according
to the severity of disease, irrespective of underlying
condition. Nevertheless, free cortisol correlated better
with endogenous ACTH than total cortisol levels, show-
ing the important feedback regulatory function of
biologically active free cortisol.
Percentage increases in total cortisol upon ACTH
underestimated those in free cortisol, since ACTH
increased the free fraction, as described before [4, 13, 17–
19]. Nevertheless, the increase in total cortisol was highly
concordant with that of free cortisol and of similar diag-
nostic value for adrenal insufficiency, particularly in
sepsis, during which CIRCI may be frequent [2–6, 8, 18,
22]. Indeed, the diagnostic similarity of total and free
cortisol increases was less in non-sepsis than in sepsis,
since binding proteins affected the former more. This
again agrees with data in healthy volunteers [11] and in
predominantly non-septic, critically ill patients and dogs
[4, 19, 20]. In non-septic patients, increases in total cor-
tisol have been suggested to underestimate increases in
free cortisol and to overestimate the occurrence of adrenal
insufficiency, even though differences between the
increases in free vs. total cortisol decrease at low
responses to ACTH [4]. The latter authors, however, did
not formally compare diagnostic values. Conversely, our
results agree with those in septic patients obtained by
others [5, 15, 21], showing good concordance of free and
total cortisol increases and diagnostic and prognostic
values, even though our cutoff value for the increase in
free cortisol was about 25% lower than suggested before
in septic patients [15]. Finally, higher endogenous ACTH
levels at relatively low versus normal exogenous ACTH-
induced total cortisol increases argue in favor of low
increases reflecting relative adrenal insufficiency, irre-
spective of baseline cortisol values.
Our data may partly explain the diagnostic and prog-
nostic value of baseline and peak total cortisol levels, of
increases upon ACTH and their combinations [1–3, 5, 6,
15, 16, 21]. The commonly observed superiority of
ACTH-induced increases in cortisol in this respect can be
explained by our data since the increases were less
dependent on binding proteins than raw levels. Baseline
total levels may also not contribute when inversely related
to increases in cortisol upon ACTH [4, 6]. Total cortisol
increases upon ACTH had somewhat greater prognostic
value than free cortisol increases in our patients, in partial
agreement with other observations [16]. Otherwise, the
role of etomidate in depressing ACTH-induced cortisol
responses has been described before, and the frequency
of low responses is also in line with the literature [1–7].
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In our relatively large and prospective study, evaluating
the clinical significance of (definitions of) relative adrenal
insufficiency, including response to hydrocortisone treat-
ment, was not the primary aim, but we still included some
clinical correlates of low cortisol responses to ACTH. The
study was designed to evaluate proper assessment of
adrenal insufficiency using an independent method of
direct free cortisol measurements in two major critical
conditions. We therefore did not attempt to redefine
clinically significant relative adrenal insufficiency from
these measurements and used values reported in the
literature for total cortisol responses to the most com-
monly used dose of 250 lg of ACTH [1–3, 5, 6].
In conclusion, our data on ACTH tests to characterize
the relative adrenal insufficiency in CIRCI suggest limited
additive diagnostic and prognostic value of assessing free
over more readily obtainable total cortisol levels, partic-
ularly when using increases in total cortisol upon ACTH,
and in sepsis as compared to non-sepsis.
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